GlassScriptPhysician profile
Ajay Aggarwal
NPI 1467413567
$41,774.25
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $32.43 · 2021: $236 · 2022: $18.46.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $41,408.00 | 2019 | |
| Epimed International, INC | $115.65 | 2021 | |
| Indivior INC. | $63.11 | 2019-2021 | |
| Horizon Therapeutics Plc | $52.98 | 2020-2021 | |
| Nevro Corp. | $27.02 | 2019 | |
| Grt US Holding, INC. | $23.58 | 2021 | |
| Metacel Pharmaceuticals LLC | $18.46 | 2022 | |
| Eisai INC. | $16.48 | 2021 | |
| Uswm, LLC | $13.92 | 2021 | |
| Mdd US Operations, LLC | $13.49 | 2019 | |
| Janssen Biotech, INC. | $12.30 | 2019 | |
| Fidia Pharma USA INC. | $9.26 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.